A new supramolecular compound, { [2-（2-pyridyl）benzimidazoleH2]2＋.[SBC15]2-}2, was synthesized by the hydrothermal reaction of o-diaminobenzene, 2-pyridinecarboxylie acid and SbCl3 in 1：1 HC1 solution, and charact...A new supramolecular compound, { [2-（2-pyridyl）benzimidazoleH2]2＋.[SBC15]2-}2, was synthesized by the hydrothermal reaction of o-diaminobenzene, 2-pyridinecarboxylie acid and SbCl3 in 1：1 HC1 solution, and characterized by chemical analysis, elemental analysis, IR spectra, thermogravimetfic analysis and fluorescence spectra. The crystal structure was deter- mined by X-ray single-crystal diffraction. The crystal belongs to the monoclinic system, space group P211c, with a = 16.0397（13）, b = 14.3189（12）, c = 15.6370（13） A, β = 105.8980（10）°, V = 3454.0（5） A3, Z = 4, C24H22Cl10N6Sb2, Mr = 992.48, Dc = 1.909 g/cm3,/z = 2.366 mm-1, S = 1.010, F（000） = 1920, R = 0.0254 and wR = 0.0555. The coordination anion, [SbCl5]2- which is a distorted tetragonal pyramid, is composed by coordinating action with Sb3＋ ion and five adjacent chloride ions. Every four coordination anions of [SbCl5]2- form a biquaternion ring structure through the secondary bonding of Sb...Cl. Moreover, the compound adopts a three-dimensional network supramolecular structure because of the hydrogen bonds and π-π stacking between the rings and the 2-（2-pyridyl）benzimidazole divalent cations. The title compound also shows good fluorescent behaviors.展开更多
A novel supramolecular compound,{[2-（2-pyridyl）benzimidazoleH2]2·[BiCl6]·Cl},was synthesized by the hydrothermal reaction of o-phenylenediamine and α-pyridinecarboxylic acid with BiCl3 in 6.0 mol·L-1...A novel supramolecular compound,{[2-（2-pyridyl）benzimidazoleH2]2·[BiCl6]·Cl},was synthesized by the hydrothermal reaction of o-phenylenediamine and α-pyridinecarboxylic acid with BiCl3 in 6.0 mol·L-1 HCl solution,and characterized by elemental analysis,IR,X-ray single-crystal diffraction and photoluminescence spectroscopy.The crystal （C24H22N6Cl7Bi,Mr= 851.61） belongs to the triclinic system,space group P1 with a =7.2887（18）,b =9.548（2）,c= 12.469（3）,α=85.306（4）,β=82.814（4）,γ=71.349（4）°,Z=1,V=814.9（3）3,Dc=1.735 g/cm3,μ（MoKα）=6.007 mm-1,F（000）=410,R=0.0307 and wR=0.0787.The bismuth ion and six chlorine ions construct a distorted octahedral configuration.The three-dimensional supramolecular network is built from electrostatic attractions,hydrogen bonds and π-π interaction between the BiCl6 anion,Cl anion and [2-（2-pyridyl）benzimidazoleH2] cation.The photoluminescence spectroscopy study shows that the title compound has a blue fluorescent emission at 450 nm in the solid state.展开更多
A novel Ru（Ⅱ） complex [（bpy）2Ru（PBC）]（PF6）2 （PBC = N-[4-（9-carbazole）butyl]-2-（2-pyridyl）benzimidazole） has been synthesized and verified by 1↑H NMR, elemental analysis and X-ray crystallography. The c...A novel Ru（Ⅱ） complex [（bpy）2Ru（PBC）]（PF6）2 （PBC = N-[4-（9-carbazole）butyl]-2-（2-pyridyl）benzimidazole） has been synthesized and verified by 1↑H NMR, elemental analysis and X-ray crystallography. The crystal （C48H40F12N8P2Ru, Mr = 1119.89） belongs to the triclinic system, space group P1, with a = 13.128（4）, b = 13.814（4）, c = 14.184（4） A, α = 84.112（6）, β = 88.473（6）, γ = 78.196（6）°, Z = 2, V = 2504.6（13）A^3, Dc = 1.485 g/cm^3, F（000） = 1132, R = 0.0750 and wR = 0.1896. The Ru atom adopts a distorted-octahedral coordination geometry with the bond distances and bond angles falling in normal ranges. The complex shows an intense metal-to-ligand charge transfer （1MLCT） （dπ（Ru） →π＊（L）） transition （ε ~1.2×10^4 dm^3mol^-1cm^-1） at 457 nm in the UV-Vis absorption spectrum and a strong red phosphorescence at 632 nm in the CH3CN solution at ambient temperature. An efficient intramolecular energy transfer process from the carbazole unit to the [（bpy）2Ru（PB）]^2＋ emissive center exists by selective optical-simulation. Its electrochemical behavior shows multiplicate redox processes based on the metal center, the grafting carbazole moiety and the 2-（2-pyridyl）benzimidazole unit.展开更多
Complexes[Zn(pbm)(5-hip)_(3)](1),[Zn(pbm)(5-nip)3](2),[Mn(pbm)(H_(3)btc)_(2)(H_(2)O)](3)and[Mn(pbm)(5-nip)_(3)](4),where H2HIPA=5-hydroxyisophthalic acid,H2nip=5-nitroisophthalic acid,H3btc=tri-mesic acid and pbm(pyri...Complexes[Zn(pbm)(5-hip)_(3)](1),[Zn(pbm)(5-nip)3](2),[Mn(pbm)(H_(3)btc)_(2)(H_(2)O)](3)and[Mn(pbm)(5-nip)_(3)](4),where H2HIPA=5-hydroxyisophthalic acid,H2nip=5-nitroisophthalic acid,H3btc=tri-mesic acid and pbm(pyridine benzene chelate material)=2-(2-pyridyl)benzimidazole,were identified via sin-gle-crystal XRD analyses.1,2 and 4 pertain to the monoclinic space group C2/c,while 3 belongs to the triclinic space group P1.The interplay of CT-DNA with those complexes was delineated using ultraviolet,fluorescence,and circular dichroism(CD)spectroscopy and viscosity measurements.Complexes 1,2,3 and 4 interact with CT-DNA in an electrostatic or grooving mode.We wish to offer a theory-wise foundation for developing anti-tumor medi-cines.展开更多
Cd(Ⅱ), Co(Ⅱ), Cu(Ⅱ) and Zn(Ⅱ) complexes(1~4) based on 2-(2-pyridyl)benzimidazole(pbm) and 4,4'-oxybisbenzoic acid(H2odc) were synthesized. The formulas of these complexes are [Cd(pbm)(odc)2](1), [Co(pbm)(odc)2...Cd(Ⅱ), Co(Ⅱ), Cu(Ⅱ) and Zn(Ⅱ) complexes(1~4) based on 2-(2-pyridyl)benzimidazole(pbm) and 4,4'-oxybisbenzoic acid(H2odc) were synthesized. The formulas of these complexes are [Cd(pbm)(odc)2](1), [Co(pbm)(odc)2](2), [Cu(pbm)(odc)2](3) and [Zn(pbm)(odc)2](4) confirmed by single-crystal X-ray diffraction analysis, which shows that complexes 1, 2 and 4 belong to monoclinic system with space group P21/n, while complex 3 belongs to monoclinic system with space group P21/c. The binding properties of complexes 1~4 with CT-DNA are evaluated by ultraviolet spectrum, fluorescence spectra and viscosity measurements. The results indicate that complexes 1~4 have strong interaction with CT-DNA binding. These complexes exhibit an electrostatic or groove mode in respect of binding with DNA, which can effectively destroy DNA. And this binding mode may be applied to the interaction between the complexes and cancer cell DNA. Therefore, we hope to provide a theoretical and scientific basis for the research of anti-cancer drugs.展开更多
基金Supported by the Natural Science Foundation of Henan Province (No. 0611023700)Natural Science Foundation of Education Department of Henan Province (No. 2006150019)
文摘A new supramolecular compound, { [2-（2-pyridyl）benzimidazoleH2]2＋.[SBC15]2-}2, was synthesized by the hydrothermal reaction of o-diaminobenzene, 2-pyridinecarboxylie acid and SbCl3 in 1：1 HC1 solution, and characterized by chemical analysis, elemental analysis, IR spectra, thermogravimetfic analysis and fluorescence spectra. The crystal structure was deter- mined by X-ray single-crystal diffraction. The crystal belongs to the monoclinic system, space group P211c, with a = 16.0397（13）, b = 14.3189（12）, c = 15.6370（13） A, β = 105.8980（10）°, V = 3454.0（5） A3, Z = 4, C24H22Cl10N6Sb2, Mr = 992.48, Dc = 1.909 g/cm3,/z = 2.366 mm-1, S = 1.010, F（000） = 1920, R = 0.0254 and wR = 0.0555. The coordination anion, [SbCl5]2- which is a distorted tetragonal pyramid, is composed by coordinating action with Sb3＋ ion and five adjacent chloride ions. Every four coordination anions of [SbCl5]2- form a biquaternion ring structure through the secondary bonding of Sb...Cl. Moreover, the compound adopts a three-dimensional network supramolecular structure because of the hydrogen bonds and π-π stacking between the rings and the 2-（2-pyridyl）benzimidazole divalent cations. The title compound also shows good fluorescent behaviors.
基金Supported by the Natural Science Foundation of Henan Province (No. 0611023700)
文摘A novel supramolecular compound,{[2-（2-pyridyl）benzimidazoleH2]2·[BiCl6]·Cl},was synthesized by the hydrothermal reaction of o-phenylenediamine and α-pyridinecarboxylic acid with BiCl3 in 6.0 mol·L-1 HCl solution,and characterized by elemental analysis,IR,X-ray single-crystal diffraction and photoluminescence spectroscopy.The crystal （C24H22N6Cl7Bi,Mr= 851.61） belongs to the triclinic system,space group P1 with a =7.2887（18）,b =9.548（2）,c= 12.469（3）,α=85.306（4）,β=82.814（4）,γ=71.349（4）°,Z=1,V=814.9（3）3,Dc=1.735 g/cm3,μ（MoKα）=6.007 mm-1,F（000）=410,R=0.0307 and wR=0.0787.The bismuth ion and six chlorine ions construct a distorted octahedral configuration.The three-dimensional supramolecular network is built from electrostatic attractions,hydrogen bonds and π-π interaction between the BiCl6 anion,Cl anion and [2-（2-pyridyl）benzimidazoleH2] cation.The photoluminescence spectroscopy study shows that the title compound has a blue fluorescent emission at 450 nm in the solid state.
基金Supported by the Natural Science Foundation of Henan Province (No. 102100410221)the Natural Science Foundation of Nanyang Normal University (No. ZX2010012)the Young Core Instructor from the Education Commission of Henan Province
文摘A novel Ru（Ⅱ） complex [（bpy）2Ru（PBC）]（PF6）2 （PBC = N-[4-（9-carbazole）butyl]-2-（2-pyridyl）benzimidazole） has been synthesized and verified by 1↑H NMR, elemental analysis and X-ray crystallography. The crystal （C48H40F12N8P2Ru, Mr = 1119.89） belongs to the triclinic system, space group P1, with a = 13.128（4）, b = 13.814（4）, c = 14.184（4） A, α = 84.112（6）, β = 88.473（6）, γ = 78.196（6）°, Z = 2, V = 2504.6（13）A^3, Dc = 1.485 g/cm^3, F（000） = 1132, R = 0.0750 and wR = 0.1896. The Ru atom adopts a distorted-octahedral coordination geometry with the bond distances and bond angles falling in normal ranges. The complex shows an intense metal-to-ligand charge transfer （1MLCT） （dπ（Ru） →π＊（L）） transition （ε ~1.2×10^4 dm^3mol^-1cm^-1） at 457 nm in the UV-Vis absorption spectrum and a strong red phosphorescence at 632 nm in the CH3CN solution at ambient temperature. An efficient intramolecular energy transfer process from the carbazole unit to the [（bpy）2Ru（PB）]^2＋ emissive center exists by selective optical-simulation. Its electrochemical behavior shows multiplicate redox processes based on the metal center, the grafting carbazole moiety and the 2-（2-pyridyl）benzimidazole unit.
文摘Complexes[Zn(pbm)(5-hip)_(3)](1),[Zn(pbm)(5-nip)3](2),[Mn(pbm)(H_(3)btc)_(2)(H_(2)O)](3)and[Mn(pbm)(5-nip)_(3)](4),where H2HIPA=5-hydroxyisophthalic acid,H2nip=5-nitroisophthalic acid,H3btc=tri-mesic acid and pbm(pyridine benzene chelate material)=2-(2-pyridyl)benzimidazole,were identified via sin-gle-crystal XRD analyses.1,2 and 4 pertain to the monoclinic space group C2/c,while 3 belongs to the triclinic space group P1.The interplay of CT-DNA with those complexes was delineated using ultraviolet,fluorescence,and circular dichroism(CD)spectroscopy and viscosity measurements.Complexes 1,2,3 and 4 interact with CT-DNA in an electrostatic or grooving mode.We wish to offer a theory-wise foundation for developing anti-tumor medi-cines.
文摘Cd(Ⅱ), Co(Ⅱ), Cu(Ⅱ) and Zn(Ⅱ) complexes(1~4) based on 2-(2-pyridyl)benzimidazole(pbm) and 4,4'-oxybisbenzoic acid(H2odc) were synthesized. The formulas of these complexes are [Cd(pbm)(odc)2](1), [Co(pbm)(odc)2](2), [Cu(pbm)(odc)2](3) and [Zn(pbm)(odc)2](4) confirmed by single-crystal X-ray diffraction analysis, which shows that complexes 1, 2 and 4 belong to monoclinic system with space group P21/n, while complex 3 belongs to monoclinic system with space group P21/c. The binding properties of complexes 1~4 with CT-DNA are evaluated by ultraviolet spectrum, fluorescence spectra and viscosity measurements. The results indicate that complexes 1~4 have strong interaction with CT-DNA binding. These complexes exhibit an electrostatic or groove mode in respect of binding with DNA, which can effectively destroy DNA. And this binding mode may be applied to the interaction between the complexes and cancer cell DNA. Therefore, we hope to provide a theoretical and scientific basis for the research of anti-cancer drugs.
